You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 8,124,799


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,124,799 protect, and when does it expire?

Patent 8,124,799 protects SKYCLARYS and is included in one NDA.

This patent has sixty patent family members in twenty-nine countries.

Summary for Patent: 8,124,799
Patent landscape, scope, and claims:
Title:Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
Abstract:This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:
Inventor(s):Anderson Eric, Jiang Xin, Visnick Melean
Assignee:Reata Pharmaceuticals, Inc.
Application Number:US12426778
Patent Claim Types:
see list of patent claims
 

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,124,799

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes 8,124,799 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.